Search Within

Igor Vivanco

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Epidemiology and Biostatistics (4)
  2. Department of Medicine (3)
  3. Department of Pathology and Laboratory Medicine (3)
  4. GSK Faculty (3)
  5. Genitourinary Oncology Service (3)
  6. Human Oncology and Pathogenesis Program (3)

More Groups

People
  1. William Pao (4)
  2. Ingo Mellinghoff (3)
  3. Adriana Heguy (2)
  4. Barry Taylor (2)
  5. Chris Sander (2)
  6. David Solit (2)

More People

Years
  1. 2010 (1)
  2. 2009 (3)
Publications
  1. Cancer Research (1)
  2. Journal of Clinical Investigation (1)
  3. Nature Genetics (1)
  4. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Society for Clinical Investigation (1)
  3. National Academy of Sciences (1)
  4. Nature Publishing Group (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies
    Journal Article

    Veeriah, S.; Taylor, B. S.; Meng, S.; Fang, F.; Yilmaz, E.; Vivanco, I.; Janakiraman, M.; Schultz, N.; Hanrahan, A. J.; Pao, W.; more...
    Nature Genetics (2010)

    Fulltext@MSK | Save
  • EGFR T790M decreases growth potential of lung tumor cells with drug-sensitive EGFR mutant alleles in the absence of drug selection
    Meeting Abstract

    Chmielecki, J.; Foo, J.; Somwar, R.; Regales, L.; Vivanco, I.; Shen, R.; Michor, F.; Pao, W.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
    Journal Article

    Veeriah, S.; Brennan, C.; Meng, S.; Singh, B.; Fagin, J. A.; Solit, D. B.; Paty, P. B.; Rohle, D.; Vivanco, I.; Chmielecki, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
    Journal Article

    Regales, L.; Gong, Y.; Shen, R.; de Stanchina, E.; Vivanco, I.; Goel, A.; Koutcher, J. A.; Spassova, M.; Ouerfelli, O.; Mellinghoff, I. K.; more...
    Journal of Clinical Investigation (2009)

    Fulltext@MSK | Save